ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,372Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 11

$424K Total Retail Price of All Prescriptions

Rank: 1 out of 11

495 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 11,823 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $38 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 684 644 1 1
LOSARTAN POTASSIUM 575 553 2 3
METOPROLOL SUCCINATE 531 527 3 12
INDAPAMIDE 471 442 10 4 21
AMLODIPINE BESYLATE 446 434 5 4
METFORMIN HCL 356 331 6 2
SYNTHROID 334 303 7 5
FAMOTIDINE 275 275 8 37
OMEPRAZOLE 264 264 9 8
LEVOTHYROXINE SODIUM 232 219 10 11
FOSINOPRIL SODIUM 231 231 11 44
HYDROCHLOROTHIAZIDE 226 214 12 17
SERTRALINE HCL 223 203 13 20
ENALAPRIL MALEATE 222 213 14 9
GABAPENTIN 219 212 15 7
ATENOLOL 207 195 16 10
PANTOPRAZOLE SODIUM 199 199 17 13
ISOSORBIDE MONONITRATE ER 167 167 18 23
LANSOPRAZOLE 167 165 18 31
PAROXETINE HCL 165 163 20 41
ZOLPIDEM TARTRATE 152 134 21 27
DIGOXIN 147 147 22 36
FUROSEMIDE 140 140 23 22
NAMENDA 129 129 24 14
TAMSULOSIN HCL 125 121 25 32
GLYBURIDE MICRONIZED 124 121 R 26 62
FLUTICASONE PROPIONATE 123 122 27 63
WARFARIN SODIUM 123 92 27 40
RANITIDINE HCL 118 108 29 6
DONEPEZIL HCL 116 116 30 15
CLOPIDOGREL 112 107 31 34
PRAVASTATIN SODIUM 111 107 32 28
LEVOXYL 106 106 33 38
ATORVASTATIN CALCIUM 105 101 34 30
COUMADIN 92 66 35 72
LISINOPRIL 92 79 35 18
FOLIC ACID 86 86 37 73
DIOVAN 83 83 38 45
PLAVIX 78 78 39 52
TRAMADOL HCL 74 73 40 26
SINGULAIR 72 72 41 90
IRBESARTAN 70 69 42 58
DOXAZOSIN MESYLATE 70 66 42 64
GLIMEPIRIDE 70 70 42 19
TERAZOSIN HCL 68 68 45 92
ACTONEL 67 67 46 93
ALLOPURINOL 65 65 47 60
PREDNISONE 63 63 48 45
DICLOFENAC POTASSIUM 63 58 48 95
GLIPIZIDE ER 61 53 50 97
DETROL LA 59 55 51 99
GALANTAMINE HBR 56 56 52 100
EVISTA 56 56 52 55
LANTUS 53 53 54 42
FINASTERIDE 53 53 54 105
CARVEDILOL 52 43 56 35
ALENDRONATE SODIUM 52 52 56 25
CRESTOR 51 51 58 106
ALPRAZOLAM 50 50 59 109
TRAMADOL HCL-ACETAMINOPHEN 50 36 59 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.